Cargando…
Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase
BACKGROUND: Uricase has proven therapeutic value in treating hyperuricemia but sufficient reduction of its immunogenicity may be the largest obstacle to its chronic use. In this study, canine uricase was modified with 5 kDa mPEG-SPA and the impact of large aggregated uricases and cross-linked conjug...
Autores principales: | Zhang, Chun, Fan, Kai, Ma, Xuefeng, Wei, Dongzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383732/ https://www.ncbi.nlm.nih.gov/pubmed/22745806 http://dx.doi.org/10.1371/journal.pone.0039659 |
Ejemplares similares
-
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
por: Sands, Earl, et al.
Publicado: (2022) -
Oral uricase eliminates blood uric acid in the hyperuricemic pig model
por: Szczurek, Paulina, et al.
Publicado: (2017) -
Immobilized uricase for automated
assay of uric acid in serum
por: León, Luis P., et al.
Publicado: (1982) -
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
por: Schlesinger, Naomi, et al.
Publicado: (2022) -
Uricase-deficient rat is generated with CRISPR/Cas9 technique
por: Yu, Yun, et al.
Publicado: (2020)